Dose–Response Effect of Antibodies to S100 Protein and Cannabinoid Receptor Type 1 in Released-Active Form in the Light–Dark Test in Mice

Earlier studies have shown that combination of antibodies to S100 protein and to cannabinoid receptor type 1 in released-active form (Brizantin) may possess anxiolytic properties and decrease nicotine dependence. Released-active form of antibodies is a novel approach that permits to modify natural f...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Dose Response
Main Authors: Kardash, Elena V., Ertuzun, Irina A., Khakimova, Gul'nara R., Kolyadin, Andrey N., Tarasov, Sergey A., Wagner, Stéphanie, Andriambeloson, Emile, Ivashkin, Vladimir T., Epstein, Oleg I.
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6043939/
https://ncbi.nlm.nih.gov/pubmed/30013455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1559325818779752
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados